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ABSTRACT (239 words) 
Background: 
Asthma is a disease affecting more boys than girls during childhood and more women than men 
in adulthood. The mechanisms behind these sex-specific differences are not yet understood. 
Objective: 
We analyzed if and how genetic factors contribute to sex-specific predisposition to childhood 
onset asthma. 
Methods: 
Interactions between sex and polymorphisms on childhood asthma risk were evaluated in the 
MAGICS/ISAAC II population on a genome-wide level and findings were validated in 
independent populations. Genetic fine mapping of sex-specific asthma association signals was 
performed and putatively causal polymorphisms were characterized in vitro by EMSA and 
luciferase activity assays. Gene and protein expression of the identified gene doublesex and mab-
3 related transcription factor 1 (DMRT1) were measured in different human tissues by 
quantitative Real-Time PCR and immunohistochemistry. 
Results: 
Polymorphisms in the testis-associated gene DMRT1 displayed interactions with sex on asthma 
status in a population of primarily clinically defined asthmatic children and non-asthmatic 
controls (lowest p=5.21x10-6). Replication of this interaction was successful in two childhood 
populations clinically assessed for asthma but showed heterogeneous results in other population 
based samples. Polymorphism rs3812523 located in the putative DMRT1 promoter was 
associated with allele-specific changes in transcription factor binding and promoter activity in 
vitro. DMRT1 expression was observed not only in testis but also in lung macrophages. 
Conclusion: 
DMRT1 might influence sex-specific patterns of childhood asthma and its expression in testis 
tissue and lung macrophages suggests a potential involvement in hormone or immune cell 
regulation. 
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CLINICAL IMPLICATIONS 
Sex-specific genetic associations identified DMRT1 as a candidate for sex-specific effects in 
childhood asthma. Expression of DMRT1 in testis and alveolar macrophages suggests its 
involvement in hormone or immune cell regulation. 
 
CAPSULE SUMMARY 
The clinical presentation of asthma differs considerably between boys and girls. Distinct genetic 
predisposition seems to be present and DMRT1 is a plausible candidate for sex-specific effects in 
childhood asthma. 
 
KEY WORDS 
asthma; genetic association; DMRT1; interaction; rs3812523; sex; SNP 
 
ABBREVIATIONS 
ALSPAC  Avon Longitudinal Study of Parents And Children 
Ankara  Clinical study population recruited in Ankara, Turkey 
AP-1  Activator Protein-1 
BAMSE   Children, Allergy, Milieu, Stockholm an Epidemiological Study 
bp  Base pair 
CI  Confidence interval 
CEU Utah residents with Northern and Western European ancestry from the CEPH collection 
COPD   Chronic obstructive pulmonary disease 
DAG   Dutch asthma GWA study 
DIP   Desquamative interstitial pneumonia 
DLR assay Dual Luciferase Reporter assay 
DMRT Doublesex and mab-3 related transcription factor 
ds  Double-stranded 
EMSA  Electrophoretic mobility shift assay 
Freiburg  Clinical study population recruited in Freiburg, Germany 
GABRIEL A Multidisciplinary Study to Identify the Genetic and Environmental Causes of Asthma 
in the European Community  
GR  Glucocorticoid receptor 
GWA  Genome-wide association 
HEK-293  Human embryonic kidney 293 cell line 
HWE  Hardy–Weinberg equilibrium 
IPF   Idiopathic pulmonary fibrosis 
ISAAC II  International Study of Asthma and Allergies in Childhood, phase II 
Jurkat   Cell line established from T cell leukemia 
kb  Kilobase pair 
LD  Linkage disequilibrium 
MAF  Minor allele frequency 
MAGICS  Multicentre Asthma Genetics In Childhood Study 
MALDI-TOF MS Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry 
Mb  Megabase pair 
MCP1   Monocyte chemotactic protein-1 
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OR  Odds ratio 
PAGE  Polyacrylamide gel electrophoresis 
PBMC  Peripheral blood mononuclear cell 
PIAMA   Prevention and Incidence of Asthma and Mite Allergy 
qRT-PCR  Quantitative Real-Time polymerase chain reaction 
rs  Reference SNP 
SNP  Single-nucleotide polymorphism 
Tomsk   Clinical study population primarily recruited in Tomsk, Russia 
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INTRODUCTION (195 words) 
During childhood, asthma prevalence is higher in boys than in girls with a ratio of up to 2:1.1 
However, female sex is a risk factor for the persistence of asthma symptoms into adulthood,2 
while remission seems to be more pronounced in boys during puberty.3 During adolescence and 
adulthood, more females than males acquire asthma4 resulting in a female predominance in 
asthma prevalence among adults.5 Changes in physiology and the hormonal milieu during 
puberty are suggested mechanisms for sex-specific disease susceptibility.6 Furthermore, gender-
specific differences in social behavior, exposure to environmental disease triggers and disease 
awareness may exist.6,7 
 
However, sex-specific differences in age of onset and persistence of asthma may also result from 
distinct dissimilarities in genetic susceptibility and in mechanisms of disease development 
between girls and boys. Identifying the genetic basis of sex-differences in asthma onset and its 
course is urgently needed to develop accurate prognostic markers and a more personalized 
approach towards therapeutic intervention. In this study we conducted a genome-wide search for 
sex-specific associations with childhood asthma, performed replication studies in seven different 
study populations, analyzed functional relevance of associated polymorphisms and approached 
the potential role of the associated gene in asthma pathogenesis. 
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METHODS (701 words) 
Genome-wide study of sex-SNP interactions on childhood onset asthma risk  
Interactions between sex and single nucleotide polymorphisms (SNP) on childhood onset asthma 
risk were analyzed on a genome-wide level in the MAGICS/ISAAC II population (see Online 
Repository methods and Table E1 for population details). A total of 1,361 subjects (703 
asthmatics with 65.3% males and 658 non-asthmatic controls with 49.7% males) with chip based 
SNP genotypes were available (Sentrix HumanHap300 BeadChip, Illumina Inc., San Diego, 
USA).8 All calculations were carried out with the PLINK software package version 1.07 using 
the following filtering parameters: minor allele frequency (MAF) ≥0.05; SNP genotyping rate 
≥0.95; Hardy-Weinberg disequilibrium p-value in the control population ≥0.0001.9 A logistic 
regression was used to model dominant SNP effects on asthma status in the complete 
MAGICS/ISAAC II data set as well as in male and female subsets. For the interaction analysis 
an additional sex-SNP interaction term was introduced in the regression model. 
 
Replication of selected interaction signals was performed in seven independent populations with 
childhood onset asthma phenotypes (ALSPAC, Ankara, BAMSE, DAG, Freiburg, PIAMA, 
Tomsk; see Online Repository methods and Table E1 for population details). 
 
Genetic fine mapping of the DMRT1 locus 
Fine mapping and linkage disequilibrium (LD) analyses were carried out in the 
MAGICS/ISAAC II data set in order to determine the extent of sex-specific asthma associations 
in the DMRT1 locus. Genetic fine mapping was performed using a tagging SNP approach based 
on HapMap data and enriched by SNPs from the 1,000 genomes project and the SNPper 
database (details in the Online Repository).10-12 Polymorphisms not present in the 
MAGICS/ISAAC II data set of chip and imputation based genotypes were genotyped by mass 
spectrometry as described previously.13,14 LD structure and tagging bins of DMRT1 in the 
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MAGICS/ISAAC II population were calculated with Haploview software (DMRT1 ±10 kb; 
MAF ≥ 0.05; pairwise LD threshold r2 ≥ 0.8).15 Dominant SNP effects on asthma status were 
determined for both sexes using PLINK. Male-specific asthma associations were investigated for 
independency in a set of conditional analyses, in which the strongest associated SNP from every 
tagging bin was individually used as a covariate in logistic regression. 
 
In silico analysis of putative SNP function  
Localization of SNPs to conserved coding regions of DMRT1 was determined by alignment of 
amino acid sequences of all human DMRT gene family members (Vector NTI Advance™ 11). 
The functional effect of nonsynonymous SNPs was assessed with the PolyPhen-2 software 
tool.16 Phylogenetic shadowing between human and mouse was investigated with the Vista 
Genome Browser (settings: DMRT1 ±10 kb flanking sequences; 70 % sequence conservation in 
window size 50 bp).17 Allele-specific changes in transcription factor binding were predicted with 
AliBaba2.1.18 
 
Electrophoretic mobility shift assay 
Allele-specific differences in DNA-protein interaction were investigated by electrophoretic 
mobility shift assays (EMSA; details in the Online Repository). Briefly, isotope-labeled DNA 
probes carrying the SNP allele of interest were incubated with nuclear protein extracts from 
HEK-293 cells and resulting DNA-protein complexes were resolved on gel. Competition 
experiments with unlabeled probes or addition of specific antibodies were used to identify DNA-
protein complexes. 
 
Dual Luciferase Reporter Assay 
Allele-specific effects on the activity of the putative DMRT1 promoter were investigated in dual 
luciferase reporter (DLR) assays (details in the Online Repository). In short, approximately 2 kb 
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of genomic sequence upstream of DMRT1 were cloned into the pGL3-Basic vector upstream of 
the Firefly luciferase gene (Figure E2 in the Online Repository; Promega, Mannheim, Germany). 
Vectors carrying the SNP allele of interest were used for transfection of HEK-293 cells and 
Firefly Luciferase activity was used as readout of promoter activity. Co-transfection of Renilla 
luciferase driven by thymidine kinase promoter was used for normalization of the Firefly 
Luciferase signal. 
 
DMRT1 expression in human tissues 
Current literature describes considerable expression of DMRT1 in testis only.19 To identify 
DMRT1 expression in further potentially relevant tissues, we conducted quantitative Real-Time 
PCR (qRT-PCR) on a cDNA library of human tissues and cell lines (details in the Online 
Repository). Expression levels of 18S rRNA and the delta-Ct method (CtDMRT1-Ct18SrRNA) were 
used to calculate relative gene expression.20 
 
DMRT1 immunohistochemistry was performed on human tissue sections from testis and lung. 
Details on ethical guidelines for sample collection and methods for immunohistochemical and 
hematoxylin staining can be found in the Online Repository. 
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RESULTS (1202 words) 
Genome-wide analysis of sex-specific effects on asthma risk and DMRT1 fine mapping 
The strongest sex-SNP interaction on asthma status was observed for rs2187366 (p=3.29x10-6), 
located 8 kb upstream of the uncharacterized gene LOC100505817 on chromosome 18 (Figure 
1). Almost identical significance levels were observed for rs4500131 and rs2146532 
(p=5.21x10-6 and p=7.45x10-6, respectively), located in the DMRT1 gene on chromosome 9p24, 
and an additional two polymorphisms in the DMRT1 locus (rs3812523 and rs1323271) were 
among the 100 strongest interaction signals (Figure 1 and Table E2-a in the Online Repository). 
Other interaction signals were distributed over the genome with no more than two signals within 
1,000 kb. Due to the known male-specific biological function of DMRT1 this locus was selected 
for further analyses, despite ranging slightly below a genome-wide significance level of 
p<1.6x10-7.19 Asthma association data for DMRT1 polymorphisms revealed protective effects for 
the minor allele in males with odds ratios (OR) < 1, while females displayed none or opposite 
effects (Figure 2 and Table E2-b,c).  
 
Replication analyses of DMRT1 polymorphisms rs4500131 and rs3812523 (r2 = 0.43 in 
MAGICS/ISAAC II) were performed in six, respectively seven, independent populations with 
childhood onset asthma. Polymorphisms rs2146532 and rs1323271 were not investigated during 
replication due to their high LD with rs4500131 (r2 = 0.98 and r2 = 0.80, respectively). 
Polymorphism rs4500131 exhibited a trend for interaction in clinical studies from Tomsk and 
Freiburg (Figure 2 and Table E3). Comparable to the MAGICS/ISAAC II population, the 
rs4500131 minor allele displayed protective effects in male asthmatics in the clinical studies 
Tomsk and DAG as well as a trend in the birth cohort PIAMA. For female asthmatics a trend for 
replication of risk effects was observed in Freiburg whereas DAG displayed a protective trend. 
For rs3812523 significant replications of the sex interaction were observed in Tomsk and 
Freiburg, as well as a significant protective effect in male asthmatics in Tomsk and a trend in 
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Ankara and PIAMA. Like for rs4500131, rs3812523 results for female asthmatics were 
inhomogeneous with a significant risk effect in Freiburg and a trend for risk in Tomsk while 
Ankara and DAG displayed trends for protective effects. 
 
Genetic fine mapping of the 147 kb DMRT1 locus in the MAGICS/ISAAC II population 
identified 182 SNPs in 58 tagging bins (DMRT1 ±10 kb; MAF ≥ 0.05; r2 ≥ 0.8). Detailed 
information on all genotyped and analyzed SNPs is provided in Table E4 in the Online 
Repository. Significant male-specific effects (pmale < 0.01) clustered to 23 polymorphisms in the 
5’ gene region. These SNPs belonged to five different tagging bins with the strongest signal 
originating from rs3812523 (Figure 3 and Table I-a). Male-specific association signals based on 
imputation for rs7022951, rs2025309, rs4338164 and rs3739583 with asthma and rs7040024 and 
rs6477321 with eczema were verified by MALDI-TOF MS (eczema data not shown and 
available from the authors upon request). 
 
In silico and conditional analyses identify rs3812523 as a candidate for functional 
investigation 
All polymorphisms with male-specific asthma associations with p < 0.01 were analyzed in silico. 
Alignment of the human DMRT protein family revealed high similarity in the amino acid 
sequence in the DM domain for DNA binding. Polymorphism rs3739583 lies outside of this 
domain and the amino acid exchange from serine to threonine was predicted to be benign (Table 
I-b). Comparison between human and mouse sequences identified five SNPs to be located in 
phylogenetically conserved regions (rs7022951, rs7858180, rs3812523, rs3739583, rs2146532) 
and allele-specific effects on transcription factor binding were predicted for four polymorphisms 
(rs7022951, rs3812523, rs6477293, rs2181402; Table I-b). Conditional analysis using the 
strongest associated SNP from every tagging bin with male-specific associations as a covariate 
revealed that associations of the remaining 22 SNPs are dependent on rs3812523 (Table I-b and 
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Table E5 in the Online Repository; detailed data on in silico analyses is available upon request 
from the authors). In conclusion, in silico and conditional analyses suggested rs3812523 to be 
the driving force for the male-specific asthma association. 
 
rs3812523 demonstrates allele-specific effects on transcription factor binding and promoter 
activity in vitro  
EMSA identified a specific DNA-protein complex for the non-risk ꞌGꞌ allele of rs3812523 
(conferring a lower risk for asthma in males) in nuclear protein extract from HEK-293 cells, 
which was not present for the risk ꞌAꞌ allele (Figure 4, complex I; lanes 3-6). Competition 
experiments demonstrated a high allele-specificity of this DNA-protein complex (Figure 4, lanes 
7-8). Competition with a high affinity AP-1 consensus site successfully abrogated the DNA-
protein complex (lane 9). The dimeric AP-1 transcription factor can be formed by different 
members of the Jun, Fos, ATF and JDP protein families.21 Antibody-specific supershift 
experiments revealed a supershift of the DNA-protein complex after incubation with a c-Jun 
antibody (lane 11) and negative results for c-Fos (lane 12), ATF-7 (lane 13) and JDP2 (data not 
shown). 
 
A second DNA-protein complex at a lower molecular weight also displayed allele-specific 
effects (complex II; lanes 3-6). However, for both alleles the cross-competitions were incomplete 
(lanes 1 and 8) illustrating that different DNA-protein complexes are overlaying at this height of 
the EMSA gel. This finding is supported by competition with the AP-1 consensus site (Figure E1 
in the Online Repository; complex II; lanes 5 and 14) leading to complete abrogation of this 
complex only in the non-risk allele. Again, c-Jun and additionally c-Fos have a role in the non-
risk allele and also in the risk allele due to antibody-specific supershifts (Figure E1; complex II; 
lanes 2,3,16,17). However, even after successful c-Jun and c-Fos supershifts, an unidentified 
complex remains visible in the risk-allele (Figure E1; complex II; lanes 2 and 3). 
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DLR assays were conducted to test if the allele-specific binding of transcription factors to 
rs3812523 observed in EMSA has an influence on the activity as a promoter. A strong increase 
in Luciferase signal between the empty pGL3-Basic vector and the two pGL3-DMRT1 vectors 
demonstrate the functionality of this putative DMRT1 promoter region (Figure 5). Comparison 
between the rs3812523 risk and non-risk alleles displayed a significantly lower expression of the 
Firefly luciferase gene under the control of the non-risk allele in all tested conditions with the 
strongest effect in unstimulated HEK-293 cells (p=0.0008). 
 
DMRT1 is expressed in testis and macrophages in the lung 
We screened a cDNA library of human tissue samples and human cell lines for DMRT1 
expression (Table E8 in the Online Repository). As expected, testis displayed strong DMRT1 
expression but lower mRNA levels were also observed in immunologically relevant cell lines 
(Jurkat and YT) and in HEK-293 cells. 
 
Immunohistochemistry for DMRT1 presented strong nuclear staining of adult testis Sertoli cells 
and possibly some germ cells (Figure 6).19 Lung tissue from patients with normal lung function 
displayed weak DMRT1 staining in alveolar macrophages. Furthermore, lung tissue from adults 
with asthma, desquamative interstitial pneumonia (DIP), chronic obstructive pulmonary disease 
(COPD) or idiopathic pulmonary fibrosis (IPF) presented a strong staining of DMRT1 in all 
alveolar macrophages and less prominent also in interstitial macrophages. In contrast to staining 
in testis tissue, DMRT1 appears to primarily locate to the cytoplasm of macrophages in the lung. 
There was no staining of granulocytes, lymphocytes or plasma cells. Appendix, thymus, lymph 
node, and spleen indicated only staining in a subset of macrophages, mainly in the germinal 
center (so-called tingible body macrophages) and vascular structures, morphologically high-
endothelial venules (Figure E3).  
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DISCUSSION (1421 words) 
Our genome-wide analysis for interactions between sex and SNP effects on childhood asthma 
risk identified a number of strong interactions close to the genome-wide significance level set for 
simple association studies. Our analysis did not replicate sex-SNP interaction results from a 
previous study on asthma in European Americans where polymorphism rs2549003, located near 
IRF1 on chromosome 5q31, displayed a significant sex-SNP interaction on asthma with male-
specific effects.22 In our data set, no trend for interaction (p=0.89) or asthma association in males 
(pmale=0.39) could be observed for rs2548997, which was described to be in complete LD with 
rs2549003 in the same study. 
 
Polymorphisms in DMRT1 displayed strong asthma associations in males and weaker but 
opposite effects in females. Replication of rs4500131 and rs3812523 (r2 = 0.43) was successful 
in some, but not in all populations. Interestingly, the clinical populations Tomsk and Freiburg 
presented the best replication of our findings, while the clinically recruited DAG population with 
algorithm based asthma diagnosis replicated part of the observations. Effects in birth cohorts 
with parental report of doctor’s asthma diagnosis were weaker or not present (ALSPAC, 
BAMSE and PIAMA). This might indicate that sex-specific effects of DMRT1 on asthma 
pathogenesis may be less pronounced in a population based milder asthma phenotype compared 
to populations recruited from tertiary clinical centers. Additionally, opposite effect directions 
between males and females as well as ambiguous effects in females from different studies could 
indicate that DMRT1 function in asthma pathogenesis might be modulated by yet unknown 
population-specific environmental factors.23 
 
Our fine mapping focused on males due to the known biological function of DMRT1 in testis 
and this approach identified that asthma associations are defined to 23 polymorphisms in the 5’-
region of DMRT1. Conditional analysis and in silico prediction suggested rs3812523, located in 
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the putative promoter of DMRT1, as the best candidate that may drive the sex-specific asthma 
association. EMSA displayed allele-specific binding of c-Jun to the non-risk allele of rs3812523, 
while a second DNA-protein complex, containing heterodimeric AP-1 (c-Jun/c-Fos), exhibited 
quantitative effects in binding affinity between risk and non-risk allele. Additionally, the risk 
allele specifically binds another yet unidentified transcription factor. In line with these 
observations, our promoter activity assays also demonstrated significant allele-specific effects 
for rs3812523. Interestingly, stimulation with PMA leads to a relatively lower promoter activity, 
which is in line with observations of inhibited DMRT1 expression in primary mice Sertoli cells 
after PMA stimulation.24 These in vitro analyses allow us to assume that also the in vivo 
expression of DMRT1 might be influenced by rs3812523, which could contribute to the 
functional relevance of the association with asthma. 
 
With DMRT1 we propose a potential factor for genetically driven differences in childhood 
asthma etiology between sexes. The doublesex and male abnormal 3 related transcription factor 
1 (DMRT1) belongs to a family of transcriptional regulators containing the DM domain DNA 
binding motif, which was first identified in a comparison of the Drosophila melanogaster gene 
doublesex and the Caenorhabditis elegans gene male abnormal 3.25 This DM domain can be 
found in a wide spectrum of animal taxa and its function in sexual differentiation has been 
reviewed in detail by Matson and Zarkower.19 For mammals Matson and Zarkower describe 
exclusive expression of DMRT1 in the gonads, which becomes male-specific during fetal testes 
differentiation. Human adult testes express DMRT1 in Sertoli cells and spermatogonia, but not in 
most other testicular cells.26 Genetic studies linked human DMRT1 with testicular germ cell 
cancer and XY gonadal disorders of sexual development.27,28 Deletion of DMRT1 in male adult 
mice caused testicular Sertoli cells to trans-differentiate towards female ovarian granulosa 
cells.29 In the same study, specific deletion of DMRT1 in fetal Sertoli cells caused elevated 
oestradiol levels and reduced androgen activity. It has been shown that DMRT1 is continuously 
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expressed in human testis from fetal stages until puberty and thereafter. However, this expression 
appears to follow a spatio-temporal expression pattern in different testis cell types, whereas in 
human ovaries DMRT1 expression is only present in early fetal stages and down-regulated 
thereafter in later fetal stages.26 One could speculate that rs3812523 driven regulation of DMRT1 
expression might to some extent influence the timing of testis development and as a consequence 
also levels and timing of sexual hormone expression. It is an attractive notion that boys carrying 
the non-risk allele benefit from an effect that might normally not occur until puberty when 
“outgrowing” of asthma symptoms is frequently observed.3 
 
However, it is possible that DMRT1 exerts its influence on asthma from another tissue than 
testis. Our cDNA screen detected DMRT1 expression in lymphoid cell lines while 
immunohistochemistry data revealed low levels of DMRT1 in alveolar macrophages in control 
lung. In contrast to this, strong DMRT1 staining was observed in the cytoplasm of alveolar 
macrophages in patients with interstitial lung disease (DIP and IPF) and patients with chronic 
obstructive pulmonary disease (COPD), which might indicate a disease associated function of 
DMRT1. Bilateral lung explants harvested during lung transplantation from adult asthmatics 
displayed DMRT1 staining similar to that in other lung diseases. However, asthma samples 
derived from adult patients with asthma accompanied by smoking-induced end-stage lung 
disease (displaying emphysematous changes and anthracosis besides histologic findings typically 
associated with asthma, such as chronic inflammation of the small airways, hypertrophy of 
bronchial smooth muscles and mucous plugs) present a considerably different phenotype than 
childhood asthmatics. Unfortunately, childhood asthma samples were not available. The sporadic 
staining of subsets of macrophages and high endothelial venules in appendix, thymus, lymph 
node, and spleen suggests that DMRT1 has a function also in these tissues outside the lung 
(Figure E3 in the Online Repository). Importantly, also female patients displayed positive 
staining of macrophages and for now and in contrast to male testis tissue this cell type appears to 
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be the only site of DMRT1 expression which could be causative for the genetic association 
signals observed in females in our analyses. Furthermore, sex-specific gene regulation has been 
suggested for DMRT1 with repression of Stra8 in male but enhancing Stra8 expression in female 
mice.30 The underlying mechanism is unknown but sex-specific gene regulation in humans by 
DMRT1 might explain the opposing effect directions of asthma associations observed between 
sexes in our study. 
 
Localization of DMRT1 to the cytoplasm of macrophages might indicate inactivation of its 
transcriptional function. Considering the regulatory function of alveolar macrophages in 
inflammatory responses of the lung,31 detailed studies on DMRT1 function in these cells need to 
follow, e.g. the potential of DMRT1 trans-localization to the nucleus upon macrophage 
activation. To date, little is known on the nuclear import of human DMRT1, but an importin-β1-
dependent mechanism has been suggested and the potential role of importins in the regulation of 
allergic immune responses has recently been reviewed.32,33 Interestingly, in an explorative study 
we observed significant correlations between rs3812523 and cytokines secreted from cultured 
peripheral blood mononuclear cells (PBMC; n=61 adults). Among others, protein levels of 
monocyte chemotactic protein-1 (MCP1), which is also produced by macrophages, were 
significantly lower in homozygous carriers of the rs3812523 risk allele compared to 
heterozygous carriers (p=0.037). Moreover, we were able to support this observation with a trend 
for lower MCP1 mRNA levels in risk allele carriers (p=0.101; details in the Online Repository 
methods and Figure E4).34 The explorative character of this analysis with relatively small sample 
size needs to be acknowledged as well as the unexpected down-regulation of the 
proinflammatory cytokine MCP1 in carriers of the risk allele for asthma, but this effect might 
serve as a first indication for transcriptional regulation of DMRT1 in immune cells, which 
warrants further investigation. 
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Finally, we also conducted sex-specific analyses for asthma associations in the MAGICS/ISAAC 
II population for all known human DMRT genes (details in the Online Repository; Table E10; 
Figure E5) and observed weak but significant associations in males in DMRT2 and DMRTB1. 
This identification of further sex-specific associations within the DMRT gene family supports 
our results for DMRT1 and suggests a possible role of further DM domain genes in childhood 
asthma. Additionally, in our sex-combined analysis we observed an asthma association of 
DMRTA1 which is a gene recently also identified in a genetic study on atopic dermatitis.35 
 
In conclusion, we present DMRT1 as a novel candidate to explain sex-specific asthma effects 
during childhood. Its role in testis development as well as also our demonstration of DMRT1 
expression in alveolar macrophages opens potential for further functional investigations. The 
precise analysis of spatio-temporal gene expression of DMRT1 will have to follow in order to 
elucidate if and how DMRT1 expression in testis or in cells of the immune system affects asthma 
pathogenesis in males and females. 
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Table I. Male-specific asthma associations in the DMRT1 locus and in silico analyses for SNP function 
a. After fine mapping of DMRT1 a total of 23 polymorphisms with male-specific effects on asthma status (pmale < 0.01) were identified in the MAGICS/ISAAC II data set. 
Information is given on pairwise LD between SNPs and their tagging SNP (*). The SNP localization within the DMRT1 gene structure and the MAF in the MAGICS/ISAAC 
II population are listed. b. In silico analyses for functional relevance of SNPs were carried out on the protein and DNA level, but also statistical effects were considered to 
identify a candidate SNP for functional in vitro analysis. Polymorphism rs3812523 in the putative promoter of DMRT1 was identified as a target for functional in vitro 
analysis. 
na: analysis method not applicable; +/-: positive or negative outcome 
a. 
             
b. 
    
     
Asthma association             
 
In silico analyses       
 
     
Sex-combined analysis 
 
Male-specific analysis 
 
Female-specific analysis 
 
Conserved AA sequence 
(human DMRT family) /  
influence on protein function 
Conserved genomic region 
(Human & Mouse) 
Allele-specific effect 
on TF binding 
Conditional 
association 
analysis 
Strongest 
association signal 
SNP Tagging 
bin 
r2 Localization MAF Odds Ratio 
(95 % CI) 
p-value Odds Ratio 
(95 % CI) 
p-value   Odds Ratio 
(95 % CI) 
p-value 
rs7022951* _1 
 
5' upstream 0.13 0.88 (0.69-1.12) 0.282 
 
0.58 (0.42-0.80) 0.0010 
 
1.54 (1.06-2.23) 0.023 
 
na + + - - 
rs16924648* _2   5' upstream 0.12 0.82 (0.63-1.06) 0.129 
 
0.58 (0.41-0.83) 0.0025 
 
1.31 (0.88-1.95) 0.179   na - - - - 
rs7858180 _6 0.93 5' upstream 0.19 0.86 (0.68-1.08) 0.188 
 
0.62 (0.46-0.85) 0.0023 
 
1.32 (0.93-1.88) 0.124 
 
na + - - - 
rs2025309* _6 
 
5' upstream 0.19 0.87 (0.70-1.08) 0.206 
 
0.64 (0.48-0.86) 0.0032 
 
1.30 (0.92-1.82) 0.138 
 
na - - na - 
rs3812523 _8 0.82 5' upstream 0.14 0.79 (0.61-1.01) 0.058 
 
0.53 (0.38-0.74) 0.00019 
 
1.31 (0.90-1.93) 0.162   na + + + + 
rs3739584 _8 0.87 
Exon 1 
5' UTR 
0.13 0.85 (0.67-1.08) 0.189 
 
0.60 (0.43-0.82) 0.0013 
 
1.36 (0.93-1.97) 0.113   na - - na - 
rs3739583 _8 0.85 
Exon 1 
(S45T) 
0.13 0.85 (0.67-1.08) 0.185 
 
0.60 (0.44-0.82) 0.0015 
 
1.33 (0.91-1.95) 0.137   -/- + - na - 
rs6477293 _8 0.90 Intron 1 0.14 0.87 (0.68-1.11) 0.267 
 
0.65 (0.47-0.90) 0.0088 
 
1.28 (0.87-1.88) 0.203   na - + na - 
rs4338164* _8   Intron 1 0.13 0.86 (0.67-1.09) 0.206 
 
0.61 (0.45-0.84) 0.0023 
 
1.32 (0.91-1.93) 0.142   na - - na - 
rs16924776 _8 0.80 Intron 1 0.13 0.85 (0.66-1.09) 0.199 
 
0.65 (0.47-0.90) 0.010 
 
1.19 (0.80-1.76) 0.394   na na na na Na 
rs16924784 _8 0.85 Intron 1 0.12 0.82 (0.63-1.06) 0.120 
 
0.57 (0.41-0.80) 0.0013 
 
1.29 (0.86-1.93) 0.211   na - - na - 
rs16924786 _8 0.85 Intron 1 0.12 0.82 (0.63-1.06) 0.120 
 
0.57 (0.41-0.80) 0.0013 
 
1.29 (0.86-1.93) 0.211   na - - na - 
rs10976974 14 0.80 Intron 1 0.22 0.90 (0.72-1.13) 0.374 
 
0.67 (0.50-0.91) 0.0094 
 
1.34 (0.95-1.90) 0.097 
 
na - - na - 
rs1323271 14 0.81 Intron 1 0.22 0.92 (0.73-1.15) 0.438 
 
0.69 (0.51-0.93) 0.015 
 
1.33 (0.94-1.89) 0.103 
 
na na na na Na 
rs2273932 14 0.96 Intron 2 0.23 0.91 (0.73-1.14) 0.410 
 
0.62 (0.46-0.84) 0.0016 
 
1.49 (1.06-2.11) 0.023 
 
na - - na - 
rs2146532 14 0.99 Intron 2 0.23 0.89 (0.71-1.11) 0.296 
 
0.61 (0.45-0.82) 0.0010 
 
1.44 (1.02-2.03) 0.037 
 
na + - na - 
rs2181402 14 0.96 Intron 2 0.23 0.91 (0.73-1.14) 0.410 
 
0.62 (0.46-0.84) 0.0016 
 
1.49 (1.06-2.11) 0.023 
 
na - + na - 
rs4500131* 14 
 
Intron 2 0.23 0.93 (0.74-1.16) 0.497 
 
0.62 (0.46-0.84) 0.0021 
 
1.54 (1.08-2.18) 0.016 
 
na - - na - 
rs6477300 14 0.96 Intron 2 0.23 0.92 (0.74-1.14) 0.443 
 
0.63 (0.47-0.84) 0.0020 
 
1.49 (1.06-2.11) 0.023 
 
na - - na - 
rs912165 14 0.96 Intron 2 0.23 0.92 (0.74-1.14) 0.443 
 
0.63 (0.47-0.84) 0.0020 
 
1.49 (1.06-2.11) 0.023 
 
na - - na - 
rs912166 14 0.96 Intron 2 0.23 0.92 (0.74-1.14) 0.443 
 
0.63 (0.47-0.84) 0.0020 
 
1.49 (1.06-2.11) 0.023 
 
na - - na - 
rs912167 14 0.99 Intron 2 0.23 0.89 (0.71-1.11) 0.296 
 
0.61 (0.45-0.82) 0.0010 
 
1.44 (1.02-2.03) 0.037 
 
na - - - - 
rs2370212 14 0.96 Intron 2 0.23 0.92 (0.74-1.14) 0.443 
 
0.63 (0.47-0.84) 0.0020 
 
1.49 (1.06-2.11) 0.023 
 
na - - na - 
rs1323265 14 0.96 Intron 2 0.23 0.92 (0.74-1.14) 0.443 
 
0.63 (0.47-0.84) 0.0020 
 
1.49 (1.06-2.11) 0.023 
 
na - - na - 
rs4740934 14 0.99 Intron 2 0.23 0.89 (0.71-1.11) 0.296 
 
0.61 (0.45-0.82) 0.0010 
 
1.44 (1.02-2.03) 0.037   na - - - - 
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Figure 1. Genome-wide interaction analysis between sex and polymorphisms on asthma risk 
The Manhattan plot depicts p-values of interactions between sex and SNPs on childhood asthma 
associations in the MAGICS/ISAAC II population. The 100 most significant observations are indicated 
above the blue line and polymorphism rs2187366 on chr. 18 obtained the lowest p-value (p=3.29x10-6). 
Top 100 interaction signals were distributed over the genome with not more than two signals within 1,000 
kb (details available from the authors upon request), except the DMRT1 locus on chr. 9, which contained 
four interaction signals within 5 kb (highlighted in green: rs4500131 p=5.21x10-6; rs2146532 p=7.45x10-
6; rs3812523 p=1.28x10-4; rs1323271 p=4.37x10-4). 
 
Figure 2. DMRT1 sex-specific effects on asthma associations 
Polymorphisms identified in the MAGICS/ISAAC II discovery population were analyzed in up to seven 
independent populations. Results for rs2146532 and rs1323271 are not shown due to high LD with rs4500131. a. 
Sex-SNP interactions on asthma association. Polymorphism rs4500131 displayed a trend for interaction in 
Tomsk, whereas replication of interaction was observed for rs3812523 in Tomsk and Freiburg. b. Sex-specific 
asthma associations. The minor allele of rs4500131 displayed protective effects in males in Tomsk and DAG and a 
trend in PIAMA. Polymorphism rs3812523 replicated this protective effect in males in Tomsk, as well as a trend in 
Ankara and PIAMA. Females showed inhomogeneous results with risk effects in some populations and a trend for 
protection in other populations. 
 
Figure 3. Fine mapping of male-specific asthma associations in DMRT1 
Genome-wide analysis identified clustering of sex-SNP interactions on asthma risk to the DMRT1 locus. 
Subsequently, DMRT1 was genetically fine mapped to determine sex-specific asthma associations. a. 
Male-specific asthma associations clustered to the 5’ region of DMRT1. In females weaker but opposite 
effects were observed (see Table I for effect directions). The localization of all analyzed SNPs within this 
area is depicted. Colored bars represent p-values (-log10) for sex-combined (yellow), male-specific (blue) 
and female-specific (red) analyses for asthma associations in the MAGICS/ISAAC II data set. b. The 
Linkage Disequilibrium (LD) structure between polymorphisms was measured by r2. 
 
Figure 4. Allele-specific binding of c-Jun to rs3812523 
Electrophoretic mobility shift assays (EMSA) were carried out for the risk and non-risk alleles of 
rs3812523 with nuclear protein extracts from HEK-293 cells without stimulation (unst.) and after 
stimulation with PMA-Ionomycin (P/I). Complex I: Distinct binding of proteins to the non-risk allele 
was observed for unstimulated and P/I-stimulated conditions (lanes 3-6). Competition with the risk-allele 
proofed specificity of protein binding to the non-risk allele (lanes 7 & 8). Competition with an AP-1 
consensus site suggested involvement of this transcription factor (lane 9). Incubation with a c-Jun 
antibody proofed c-Jun binding by retardation of the DNA-protein complex (lane 11). Antibody tests for 
additional AP-1 associated molecules c-Fos and ATF-7 showed no effect (lanes12 and 13). Complex II: 
Further allele-specific effects were observed (lanes 3-6) which were shown to involve different 
overlaying DNA-protein complexes due to incomplete cross-competitions (lanes 1 and 8). Further 
information on the identity of these complexes is given in Figure E1 in the Online Repository. 
† unrelated ds DNA probe 
‡ unrelated antibody 
 
Figure 5. Influence of rs3812523 on promoter activity 
Expression of Firefly luciferase proofed functionality of the genomic sequence upstream of DMRT1 as a 
promoter compared to the empty vector. Substitution of the rs3812523 risk allele with the non-risk allele 
caused a significant decline in promoter activity in all tested conditions. 
Firefly luciferase expression was normalized to expression of Renilla luciferase in the same sample 
(FLuc/RLuc ratio). The conditions “unstimulated” and “PMA25ng/ml; Ionomycin0.5µM” represent six 
samples. “PMA12.5ng/ml; Ionomycin0.25µM” represents eight samples. 
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Figure 6. Immunohistochemistry for DMRT1 
DMRT1 staining in adult testis tissue was present in nuclei of Sertoli cells and possibly immature germ 
cells. Lung tissue from patients with normal lung function showed weak DMRT1 staining in alveolar 
macrophages, whereas tissue from patients with different lung diseases displayed strong DMRT1 staining 
in all alveolar macrophages and to a lower extent also in interstitial macrophages. Staining in the lung 
was compatible with localization of DMRT1 to the cytosolic compartment. No staining was observed in 
granulocytes, lymphocytes or plasma cells. 
Asthma: asthma bronchiale (adult patient with accompanying emphysematous changes) 
DIP: desquamative interstitial pneumonia 
COPD: chronic obstructive pulmonary disease  
IPF: idiopathic pulmonary fibrosis 
Tissue samples from asthmatic lung were kindly provided by the Institute of Pathology (Hannover Medical School, Germany). 
All other tissue samples were kindly provided by the Department of Pathology and Medical Biology (University of Groningen, 
The Netherlands) 
